Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin

Virology Journal

Volumn 9, Issue , 2012, Pages

  Stray, Stephen J ^a   Pittman, Lindsey B ^a,b,c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INFLUENZA VIRUS HEMAGGLUTININ;

ARTICLE; CRYSTAL STRUCTURE; GENE SEQUENCE; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOPHYSICAL PHENOMENA; COMPUTATIONAL BIOLOGY; EVOLUTION, MOLECULAR; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; MUTATION, MISSENSE; PROTEIN BINDING; STATIC ELECTRICITY;

CERCOPITHECINE HERPESVIRUS 1; ORTHOMYXOVIRIDAE;

EID: 84860606034     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-91     Document Type: Article

References (53)

1. Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Desselberger U, Nakajima K, Alfino P, Pedersen F, Haseltine W, Hannoun C, Palese P, Proc Natl Acad Sci U S A 1978 75 3341 3345 10.1073/pnas.75.7.3341 277933 (Pubitemid 8389723)
2. Antigenic variation in current influenza A viruses: evidence for a high frequency of antigenic 'drift' for the Hong Kong virus. Schild G, Oxford J, Dowdle W, Coleman M, Pereira M, Chakraverty P, Bull World Health Organ 1974 51 1 11 4218138
3. M2e-based universal influenza A vaccine. Fiers W, De Filette M, El Bakkouri K, Schepens B, Roose K, Schotsaert M, Birkett A, Saelens X, Vaccine 2009 27 6280 6283 10.1016/j.vaccine.2009.07.007 19840661
4. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Wang T, Tan G, Hai R, Pica N, Ngai L, Ekiert D, Wilson I, García-Sastre A, Moran T, Palese P, Proc Natl Acad Sci U S A 2010 107 18979 18984 10.1073/pnas.1013387107 20956293
5. The quantitative determination of influenza virus and antibodies by means of red cell agglutination. Hirst G, J Exp Med 1942 75 49 64 10.1084/jem.75.1.49 19871167
6. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Wiley DC, Wilson IA, Skehel JJ, Nature 1981 289 373 378 10.1038/289373a0 6162101 (Pubitemid 11135143)
7. Structural basis of immune recognition of influenza virus hemagglutinin. Wilson IA, Cox NJ, Annu Rev Immunol 1990 8 737 771 10.1146/annurev.iy.08.040190. 003513 2188678 (Pubitemid 20135645)
8. Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase. Air GM, Els MC, Brown LE, Laver WG, Webster RG, Virology 1985 145 237 248 10.1016/0042-6822(85)90157-6 2411049 (Pubitemid 15016445)
9. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Colman PM, Laver WG, Varghese JN, Baker AT, Tulloch PA, Air GM, Webster RG, Nature 1987 326 358 363 10.1038/326358a0 2436051 (Pubitemid 17053764)
10. Defining the requirements for an antibody epitope on influenza virus neuraminidase: How tolerant are protein epitopes? Nuss JM, Air GM, J Mol Biol 1994 235 747 759 10.1006/jmbi.1994.1025 7507170 (Pubitemid 24063591)
11. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase. Nuss JM, Whitaker PB, Air GM, Proteins, Struct, Funct Genet 1993 15 121 132 10.1002/prot.340150204 (Pubitemid 23060592)
12. Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10. Lee J, Air G, Virology 2002 300 255 268 10.1006/viro.2002.1564 12350356
13. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. Venkatramani L, Bochkareva E, Lee J, Gulati U, Laver W, Bochkarev A, Air G, J Mol Biol 2006 356 651 663 10.1016/j.jmb.2005.11.061 16384583 (Pubitemid 43139327)
14. Molecular recognition in antibody-antigen complexes. Sundberg EJ, Mariuzza RA, Adv Protein Chem 2002 61 119 160 12461823 (Pubitemid 35303456)
15. Darwin C, On the origin of species by means of natural selection Murray, J, London 1859
16. The Influenza Virus Resource at the National Center for Biotechnology Information. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D, J Virol 2008 82 596 601 10.1128/JVI.02005-07 17942553
17. Natural selection on the influenza virus genome. Suzuki Y, Mol Biol Evol 2006 23 1902 1911 10.1093/molbev/msl050 16818477 (Pubitemid 44412876)
18. Positive slelection on hemagglutinin and neuraminidase genes of H1N1 influenza viruses. Li W, Shi W, Qiao H, Ho S, Luo A, Zhang Y, Zhu C, Virol J 2011 8 183 10.1186/1743-422X-8-183 21507270
19. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Edgar R, Nucleic Acids Res 2004 32 1792 1797 10.1093/nar/gkh340 15034147 (Pubitemid 38832724)
20. Kalign, Kalignvu and Mumsa: web servers for multiple sequence alignment. Lassmann T, Sonnhammer E, Nucleic Acids Res 2006 34 596 W599 10.1093/nar/gkl191 16845078 (Pubitemid 44529839)
21. Hubbard S, Thornton J, NACCESS Faculty of Life Sciences, University of Manchester 1996
22. Prediction of binding energetics from structure using empirical parameterization. Baker BM, Murphy KP, Methods Enzymol 1998 295 294 315 9750224 (Pubitemid 29349919)
23. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1) subtype. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W, Cell 1982 31 417 427 10.1016/0092-8674(82)90135-0 6186384 (Pubitemid 13178866)
24. Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Krystal M, Young JF, Palese P, Wilson IA, Skehel JJ, Wiley DC, Proc Nat'l Acad Sci USA 1983 80 4527 4531 10.1073/pnas.80.14.4527 23143977 (Pubitemid 13077872)
25. Antigenic structure of influenza virus hemagglutinin defined by hybridoma antibodies. Gerhard W, Yewdell J, Frankel M, Webster RG, Nature 1981 290 713 717 10.1038/290713a0 6163993 (Pubitemid 11068963)
26. Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 resolution. Wilson IA, Skehel JJ, Wiley DC, Nature 1981 289 366 373 10.1038/289366a0 7464906
27. The epitope regions of H1-subtype influenza A, with application to vaccine efficacy. Deem M, Pan K, Protein Eng Des Sel 2009 22 543 546 10.1093/protein/gzp027 19578121
28. Structural basis of preexisting immunity to the 2009 H1N1pandemic influenza virus. Xu R, Ekiert D, Krause J, Hai R, Crowe JJ, Wilson I, Science 2010 328 357 360 10.1126/science.1186430 20339031
29. Influenza virus infection of desialylated cells. Stray SJ, Cummings RD, Air GM, Glycobiology 2000 10 649 658 10.1093/glycob/10.7.649 10910970 (Pubitemid 30616200)
30. Selective Pressure to Increase Charge in Immunodominant Epitopes of the H3 Hemagglutinin Influenza Protein. Pan K, Long J, Sun H, Tobin G, Nara P, Deem M, J Mol Evol 2011 72 90 103 10.1007/s00239-010-9405-4 21086120
31. Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region. Yewdell J, Taylor A, Yellen A, Caton A, Gerhard W, Bächi T, J Virol 1993 67 933 942 7678310 (Pubitemid 23032072)
32. Influenza virus entry and infection require host cell N-linked glycoprotein. Chu V, Whittaker G, Proc Nat'l Acad Sci USA 2004 101 18153 18158 10.1073/pnas.0405172102 23143977 (Pubitemid 40054089)
33. Predicting the evolution of human influenza A. Bush R, Bender C, Subbarao K, Cox N, Fitch W, Science 1999 286 1921 1925 10.1126/science.286.5446.1921 10583948 (Pubitemid 129515893)
34. A maximum likelihood method for detecting directional evolution in protein sequences and its application to influenza A virus. Kosakovsky Pond S, Poon A, Leigh Brown A, Frost S, Mol Biol Evol 2008 25 1809 1824 10.1093/molbev/msn123 18511426
35. X-ray snapshots of the maturation of an antibody response to a protein antigen. Li Y, Li H, Yang F, Smith-Gill SJ, Mariuzza RA, Nat Struct Biol 2003 10 482 488 10.1038/nsb930 12740607 (Pubitemid 36637647)
36. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Skehel JJ, Wiley DC, Annu Rev Biochem 2000 69 531 569 10.1146/annurev.biochem.69.1.531 10966468
37. Three-dimensional structures of influenza virus neuraminidase-antibody complexes. Colman PM, Tulip W, Varghese JN, Tulloch PA, Baker AT, Laver WG, Air GM, Webster RG, Phil Trans Roy Soc London B 1989 323 511 518 10.1098/rstb.1989.0028 2569208
38. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). Gulati U, Hwang C, Venkatramani L, Gulati S, Stray S, Lee J, Laver W, Bochkarev A, Zlotnick A, Air G, J Virol 2002 76 12274 12280 10.1128/JVI.76.23.12274-12280.2002 12414967 (Pubitemid 35304325)
39. Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. Sundberg EJ, Urrutia M, Braden BC, Isern J, Tsuchiya D, Fields BA, Malchiodi EL, Tormo J, Schwarz FP, Mariuzza RA, Biochemistry 2000 39 15375 15387 10.1021/bi000704l 11112523 (Pubitemid 32002764)
40. Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity. Sinha N, Mohan S, Lipschultz C, Smith-Gill S, Biophys J 2002 83 2946 2968 10.1016/S0006-3495(02) 75302-2 12496069 (Pubitemid 36041920)
41. Electrostatics in protein binding and function. Sinha N, Smith-Gill S, Curr Protein Pept Sci 2002 3 601 614 10.2174/1389203023380431 12470214 (Pubitemid 35331545)
42. Evolutionary changes in influenza B are not primarily governed by antibody selection. Air GM, Gibbs AJ, Laver WG, Webster RG, Proc Nat'l Acad Sci 1990 87 3884 3888 10.1073/pnas.87.10.3884 23143977 (Pubitemid 20182564)
43. Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift. Memoli M, Jagger B, Dugan V, Qi L, Jackson J, Taubenberger J, J Infect Dis 2009 200 1232 1241 10.1086/605893 19743921
44. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Wrammert J, Smith K, Miller J, Langley W, Kokko K, Larsen C, Zheng N, Mays I, Garman L, Helms C, et al. Nature 2008 453 667 671 10.1038/nature06890 18449194 (Pubitemid 351769295)
45. V region gene usage and somatic mutation in the primary and secondary responses to influenza virus hemagglutinin. Clarke S, Staudt L, Kavaler J, Schwartz D, Gerhard W, Weigert M, J Immunol 1990 144 2795 2801 2108213 (Pubitemid 20136692)
46. A set of closely related antibodies dominates the primary antibody response to the antigenic site CB of the A/PR/8/34 influenza virus hemagglutinin. Kavaler J, Caton AJ, Staudt LM, Schwartz D, Gerhard W, J Immunol 1990 145 2312 2321 2118933 (Pubitemid 20343401)
47. Many variable region genes are utilized in the antibody response of BALB/c mice to the influenza virus A/PR/8/34 hemagglutinin. Caton A, Stark S, Kavaler J, Staudt L, Schwartz D, Gerhard W, J Immunol 1991 147 1675 1686 1908881
48. A new concept of the epidemic process of influenza A virus. Hope-Simpson R, Golubev D, Epidemiol Infect 1987 99 5 54 10.1017/S0950268800066851 3301379
49. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Hensley S, Das S, Bailey A, Schmidt L, Hickman H, Jayaraman A, Viswanathan K, Raman R, Sasisekharan R, Bennink J, Yewdell J, Science 2009 326 734 736 10.1126/science.1178258 19900932
50. Receptor binding specificity of recent human H3N2 influenza viruses. Kumari K, Gulati S, Smith D, Gulati U, Cummings R, Air G, Virol J 2007 4 42 10.1186/1743-422X-4-42 17490484 (Pubitemid 46817314)
51. Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. Gulati U, Wu W, Gulati S, Kumari K, Waner J, Air G, Virology 2005 339 12 20 10.1016/j.virol.2005.05.009 15950996 (Pubitemid 41096061)
52. Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses. Gulati S, Smith D, Air G, Virol J 2009 6 22 10.1186/1743-422X-6-22 19216793
53. "Boom" and "Bust" cycles in virus growth suggest multiple selective forces in influenza A evolution. Thangavel R, Reed A, Norcross E, Dixon S, Marquart M, Stray S, Virol J 2011 8 180 10.1186/1743-422X-8-180 21501520